"future placement of tooth implants if needed will be much easier," he said.
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims.
. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire.
.
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world.
.
.
.